Life Sciences BPO Market To Expand Industry Growth At USD 827.5 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhya3ti5UqQC187Qv2vi75nRuBRDUBZm_ZAMlMbo-UGWXf3VTVf9TM07x9h7s6IBXQhX3DfXRP1oNX_mfLJPNYyr5YZ0h4en8tEeNhER1xxAeuZgXhYyjMaYRmhFL1ubKrRGF93W-sjBWV1VgIVSegvTj12BYLioPil9SEPtIkw0_afB3Cy2rotOdSUqw/s320/Life%20Sciences%20BPO%20Market.png)
San Francisco, 17 Aug 2022: The Report Life Sciences BPO Market Size, Share & Trends Analysis Report By Service (Medical Devices Outsourcing, Pharmaceutical Outsourcing), By Region (North America, APAC), And Segment Forecasts, 2022 - 2030 The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.2% over the forecast years, according to a new report by Grand View Research, Inc. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are some of the major factors driving the market. The pharmaceutical and biotech industries invest heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of drug development, such as drug discovery, pre-clinical studies, and clinical trials, require huge financial, technological, and human resources. To c